BioSpace News Archive

Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced that George C. Murray has joined the company effective May 26, 2021 as Vice President, Global Operations and Supply Chain.

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (“Actinium” or the “Company”) today announced that three abstracts highlighting data and findings from the Company’s pivotal Phase 3 SIERRA trial for lead program Iomab-B, have been accepted for 2 oral and 2 poster presentations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting,

GE Healthcare is collaborating with the American College of Cardiology through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for Artificial Intelligence and digital technology in cardiology and developing new strategies for improved health outcomes.

City of Hope physicians and scientists will present updated research on a potential immunotherapy for multiple myeloma, a study on chimeric antigen receptor T cell therapy for brain tumors and an investigational drug for advanced urothelial carcinoma, among other studies on leading-edge cancer treatments, during the 2021 American Society of Clinical Oncology’s Annual Meeting.

BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW)(TSX-V:BCT) (the “Company” or “BriaCell”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, today announced that it has entered into definitive securities purchase agreements with accredited investors, which will result in gross proceeds to BriaCell of approximately US$27.2 million

Zynerba Pharmaceuticals, Inc., the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting a poster from 10:00 a.m. – 11:00 a.m.

Eli Lilly and Company will participate in the Goldman Sachs Healthcare Conference on June 9 and 10, 2021.

The Center for Cancer and Blood Disorders (The CenterTX) and Deep Lens today announced that they will partner to deploy artificial intelligence (AI)-based clinical trial screening and enrollment solution, VIPER™, into the Texas-based network.

The U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic’s Heartware Ventricular Assist Device (HVAD) System due to a growing body of observational clinical comparisons

FasterCures, a center of the Milken Institute, released a set of recommendations that can be used to mobilize an early warning system for global pandemic threats.